rs2134697

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.910-8444G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.635 in 152,102 control chromosomes in the GnomAD database, including 33,235 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 33235 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0200

Publications

10 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
NM_007348.4
MANE Select
c.910-8444G>A
intron
N/ANP_031374.2
ATF6
NM_001437597.1
c.910-8444G>A
intron
N/ANP_001424526.1
ATF6
NM_001410890.1
c.910-8444G>A
intron
N/ANP_001397819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
ENST00000367942.4
TSL:1 MANE Select
c.910-8444G>A
intron
N/AENSP00000356919.3
ATF6
ENST00000681492.1
c.910-8444G>A
intron
N/AENSP00000506139.1
ATF6
ENST00000680688.1
c.910-8444G>A
intron
N/AENSP00000504865.1

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96470
AN:
151984
Hom.:
33214
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.345
Gnomad AMI
AF:
0.655
Gnomad AMR
AF:
0.753
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.638
Gnomad SAS
AF:
0.664
Gnomad FIN
AF:
0.795
Gnomad MID
AF:
0.763
Gnomad NFE
AF:
0.746
Gnomad OTH
AF:
0.685
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.635
AC:
96523
AN:
152102
Hom.:
33235
Cov.:
32
AF XY:
0.639
AC XY:
47495
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.345
AC:
14312
AN:
41460
American (AMR)
AF:
0.754
AC:
11521
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2746
AN:
3472
East Asian (EAS)
AF:
0.639
AC:
3310
AN:
5180
South Asian (SAS)
AF:
0.665
AC:
3206
AN:
4822
European-Finnish (FIN)
AF:
0.795
AC:
8414
AN:
10584
Middle Eastern (MID)
AF:
0.759
AC:
223
AN:
294
European-Non Finnish (NFE)
AF:
0.746
AC:
50746
AN:
67986
Other (OTH)
AF:
0.688
AC:
1452
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1563
3125
4688
6250
7813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.715
Hom.:
175117
Bravo
AF:
0.623
Asia WGS
AF:
0.696
AC:
2419
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.6
DANN
Benign
0.80
PhyloP100
0.020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2134697; hg19: chr1-161780979; API